IDEXX Laboratories Inc (IDXX)
476.38
-1.28
(-0.27%)
USD |
NASDAQ |
Apr 19, 16:00
476.38
0.00 (0.00%)
After-Hours: 16:29
IDEXX Laboratories Free Cash Flow (Quarterly): 217.30M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 217.30M |
| September 30, 2023 | 238.34M |
| June 30, 2023 | 172.84M |
| March 31, 2023 | 144.40M |
| December 31, 2022 | 124.20M |
| September 30, 2022 | 151.32M |
| June 30, 2022 | 35.76M |
| March 31, 2022 | 72.87M |
| December 31, 2021 | 178.18M |
| September 30, 2021 | 142.19M |
| June 30, 2021 | 211.37M |
| March 31, 2021 | 104.26M |
| December 31, 2020 | 204.74M |
| September 30, 2020 | 173.66M |
| June 30, 2020 | 183.59M |
| March 31, 2020 | -21.80M |
| December 31, 2019 | 109.50M |
| September 30, 2019 | 94.94M |
| June 30, 2019 | 103.32M |
| March 31, 2019 | -3.828M |
| December 31, 2018 | 95.80M |
| September 30, 2018 | 78.99M |
| June 30, 2018 | 91.18M |
| March 31, 2018 | 11.17M |
| December 31, 2017 | 99.11M |
| Date | Value |
|---|---|
| September 30, 2017 | 94.56M |
| June 30, 2017 | 95.27M |
| March 31, 2017 | 7.627M |
| December 31, 2016 | 85.92M |
| September 30, 2016 | 88.23M |
| June 30, 2016 | 94.92M |
| March 31, 2016 | 5.084M |
| December 31, 2015 | 63.93M |
| September 30, 2015 | 56.30M |
| June 30, 2015 | 56.31M |
| March 31, 2015 | -37.66M |
| December 31, 2014 | 9.284M |
| September 30, 2014 | 76.17M |
| June 30, 2014 | 67.65M |
| March 31, 2014 | 22.04M |
| December 31, 2013 | 49.26M |
| September 30, 2013 | 62.45M |
| June 30, 2013 | 55.38M |
| March 31, 2013 | 0.264M |
| December 31, 2012 | 54.53M |
| September 30, 2012 | 55.76M |
| June 30, 2012 | 48.76M |
| March 31, 2012 | 4.838M |
| December 31, 2011 | 43.64M |
| September 30, 2011 | 61.45M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-21.80M
Minimum
Mar 2020
238.34M
Maximum
Sep 2023
139.00M
Average
144.40M
Median
Mar 2023
Free Cash Flow (Quarterly) Benchmarks
| Stryker Corp | 1.383B |
| Haemonetics Corp | -22.83M |
| Align Technology Inc | 13.48M |
| Edwards Lifesciences Corp | 35.00M |
| ACADIA Pharmaceuticals Inc | 85.39M |